Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
UTI Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.23
1.99
NAV
₹354.64
₹548.45
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1429.84 Cr
₹5870.00 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
5.98%
7.37%
3 Year
19.93%
20.57%
5 Year
13.58%
16.17%
Equity
94.12%
95.53%
Cash
5.85%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
